Evogene Ltd. announced a strategic reset that will see the company abandon its diversified ag‑biotech model and focus exclusively on its ChemPass AI platform, which it positions as a generative‑AI engine for discovering and optimizing small‑molecule drugs and agricultural chemicals.
The announcement follows a series of divestments that began in 2025, including the sale of Lavie Bio to ICL and the licensing of Biomica’s lead oncology candidate. The company also completed a 30 % workforce reduction, a cost‑saving measure that is expected to take effect from the third quarter of 2025 onward.
Evogene’s CEO, Ofer Haviv, said, “Evogene is at a turning point – becoming a focused, AI‑driven company built around our core engine, ChemPass AI.” He added that the platform’s 38‑billion‑molecule universe will enable the company to accelerate the design of molecules that meet potency, novelty, and commercial viability criteria simultaneously.
The shift is driven by the company’s view that the $780 billion pharmaceutical market offers greater value potential than the $79 billion crop‑protection market. By concentrating resources on the higher‑margin pharma sector while maintaining a presence in agriculture, Evogene aims to unlock long‑term growth and improve financial economics.
Evogene’s capital‑efficient structure is supported by proceeds from asset sales, which left the company with a cash balance of approximately $16 million as of September 30 2025. The company has not disclosed a specific cash runway, but the divestments and workforce cuts are intended to extend its liquidity while it scales the ChemPass AI platform.
Strategic partnerships reinforce the new focus. Evogene has expanded its collaboration with Google Cloud to integrate AI agents into ChemPass AI, and it continues to work with Bayer and Corteva through its AgPlenus subsidiary to develop agricultural chemicals.
The announcement marks a significant transformation, positioning Evogene as a niche AI‑driven drug‑discovery partner for biotech and pharma companies while retaining a foothold in the agricultural sector. The company’s leadership views the change as essential to unlocking long‑term value and improving its financial profile.
revised_sentiment_rating":0}]}
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.